These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2110048)

  • 1. Testosterone reduces the bioactivity of luteinizing hormone (LH) in man.
    Tsatsoulis A; Shalet SM; Richardson P; Robertson WR
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):73-82. PubMed ID: 2110048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in man.
    Tsatsoulis A; Shalet SM; Robertson WR
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):189-94. PubMed ID: 3150321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive.
    Mitchell R; Hollis S; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1995 May; 42(5):501-7. PubMed ID: 7621569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
    Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
    Carani C; Celani MF; Zini D; Baldini A; Della Casa L; Marrama P
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):284-8. PubMed ID: 2648724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group.
    Winters SJ; Atkinson L
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):317-22. PubMed ID: 9373453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pulsatile secretion of bioactive luteinising hormone in normal adult men.
    Talbot JA; Rodger RS; Shalet SM; Littley MD; Robertson WR
    Acta Endocrinol (Copenh); 1990 May; 122(5):643-50. PubMed ID: 2112817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative changes in LH secretion following pulsatile GnRH therapy in a man with idiopathic hypogonadotrophic hypogonadism.
    Tsatsoulis A; Shalet SM; Talbot A; Robertson WR
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):167-75. PubMed ID: 2692879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of pulsatile gonadotropin secretion by testosterone in man.
    Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):609-14. PubMed ID: 6421864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
    Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
    J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM; Padmanabhan V; Kelch RP; Brown MB; Olton PR; Sonstein JS; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma inhibin levels following pulsatile gonadotrophin-releasing hormone therapy in a man with idiopathic hypogonadotrophic hypogonadism.
    Tsatsoulis A; Morris ID; Shalet SM; Robertson WR; de Kretser DM
    Horm Res; 1990; 33(1):18-21. PubMed ID: 2115857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men.
    Nieschlag E; Cüppers HJ; Wiegelmann W; Wickings EJ
    Horm Res; 1976; 7(3):138-45. PubMed ID: 1002121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of secretion of bioactive and immunoreactive gonadotrophins in normal pubertal children.
    Dunger DB; Villa AK; Matthews DR; Edge JA; Jones J; Rothwell C; Preece MA; Robertson WR
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):267-75. PubMed ID: 1742886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive luteinizing hormone in plasma of uraemic men and men with primary testicular damage.
    Handelsman DJ; Spaliviero JA; Turtle JR
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):259-66. PubMed ID: 3708876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.